CATALAYER NEWS

In crowded kidney disease space, Otsuka receives FDA approval for first-in-class Voyxact - Fierce Pharma

Source: Fierce Pharma · 2025-11-26

Full article text is available in the Catalayer news terminal.

RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsTech IPO & Private Market News
RELATED MARKETS
Prediction Markets
New Rihanna Album before GTA VI?50%New Playboi Carti Album before GTA VI?50%Will Jesus Christ return before GTA VI?50%
Open Catalayer terminal for live tracking →